Regnum Corporation (CE) (RGMP) Share Price

'Grace Period' designation on, will head to Expert Market in 14 days (Oct 16th).

If they resume filing, I might take a chance on it but I'm not sure that's going to happen, seems more likely they may be winding down here instead. Its one of their only remaining assets, so it could still be sold... but.... with Shkreli's name connected to it, it's kind of tainted and would be risky for anyone to use in a merger IMO.

https://martinshkrelilacksjudgment.wordpress.com/2023/05/31/regnum-seems-to-be-winding-down-as-the-phoenixus-group-sets-our-details-in-the-reorganization-in-bankruptcy-course/

RGMP took a lotto tix here on tiny float Share Structure
Market Cap Market Cap
1,147,500
08/17/2023
Authorized Shares
80,000,000
08/16/2023
Outstanding Shares
22,950,000
08/16/2023
Restricted
22,680,000
08/16/2023
Unrestricted
270,000
08/16/2023
Held at DTC
250,000
08/16/2023

Down to Pink Limited Info today.

Wonder who has been buying this lately, two of the highest volume days ever have been in the last several days...?? I dont see anything happening, Phoenixus AG and all its subs have filed for BK and are selling off their assets. There are no company officers left here, Anne Kirby resigned and Robert Stubblefield is now the new CFO of Lottery.Com. The 10Q is quite late and they will be banished to Expert, unless they file in time, within the next 30 - 60 days I believe.

The volume is interesting but buying also seems pretty dangerous as well.

Saw in the latest Q Phoenixus has filed for bankruptcy.

NOTE 9. SUBSEQUENT EVENTS

On May 9, 2023, Phoenixus and its subsidiaries Vyera, Oakrum Pharma, LLC, SevenScore Pharmaceuticals, LLC, Dermelix Biotherapeutics, LLC, and Orpha Labs AG filed petitions for relief under subchapter V of chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (such petitions, collectively, the “Phoenixus Bankruptcy”). The Company is presently evaluating the potential impact of the Phoenixus Bankruptcy on the Company, including the potential impact on the Shared Services Agreements and the 2021 Note. The Phoenixus Bankruptcy may also require or otherwise eventuate in a future sale of a portion or all of the Common Stock held by Phoenixus. However, given that filings for the Phoenixus Bankruptcy were only recently made, the potential impact of the Phoenixus Bankruptcy on the Company is uncertain.

Not sure you saw this...but some serious house cleaning took place last week.

"The Purge" occurred on 25Aug22.

https://nypost.com/2022/08/25/pharma-bro-martin-shkreli-booted-from-his-company-by-activist-revolt/

House cleaning in progress at many places Marty has touched over the years. Likely going to take a while to cleanse the SEC's palette of Marty's former presence.

I saw in the latest Q FINRA is not letting them change the name of the company to Rovida Therapeutics, does not sound like there is any recourse left either.......any merger or acquisition would likely be blocked by FINRA as well.....not many options left here but to sell this or give up on it completely.

On October 21, 2021, the Company submitted a Company Related Action Notification in accordance with Financial Industry Regulatory Authority (“FINRA”) Rule 6490 in connection with a proposed change of the Company’s name to “Rovida Therapeutics, Inc.,” the redomicile of the Company from Nevada to Delaware and a change in the Company’s ticker symbol (the “Corporate Actions”). The Corporate Actions have been approved by the board of directors of the Company and by Phoenixus as the holder of majority of the outstanding shares of common stock, $0.001 par value per share, of the Company (the “Common Stock”). The Company’s application for FINRA approval of the Corporate Actions was denied by FINRA’s Department of Market Operations due to Phoenixus’s former association with Martin Shkreli as disclosed in the Company’s 2021 Form 10-K. The Company appealed FINRA’s determination to a subcommittee of FINRA’s Uniform Practice Code Committee, and on July 28, 2022, the Company’s appeal was denied by such subcommittee. As a result, the Corporate Actions will not be implemented, and given the appeal decision, the Company anticipates that it will take no further action on the Corporate Actions at this time.

Wonder when anyone will notice that regnum has selling rights in USA
Something is going on with cydy so I would expect some news there
there is low float so this will fly again when the news hits, wonder if regnum already knows and that is why they kept this pink current , then next will be their game plan in relation to cydy and a fund raise to get more shares in market and have funds to execute plans

I dont think this will retreat in price like last time as cydy appears to be ready to move forward with new ceo

I thought this would move after cytodyn gets clearance on the hold.
cytodyn stock is up from under .50 to over .75 in less than 30 days because as I think people believe the new Pres will clear a path forward for cytodyn

You seem to follow cytodyn closer than I do even though I also own that stock, some boards get to busy with no relevant info, I get the impression they are working the HIV thing in other countries that are not completely bought off by BigPharma to shut any HIV drug down in USA.

I also think that cytodyn will start pushing other uses more now with a little cash they have, will issue more shares to pay off samsaung or give them some ownership, either way working on a deal with samsung should be looked at positively. Even though I dont think samsung wants ownership as that may conflict with other drug companies they do work for, also assuming samsung runs into this situation all the time so they will just negotiate good terms for the debt.

unfortunately we have seen this takes time because the previous cytodyn management blew too many opportunities

Agree, keeping a clean shell with knowledge and contacts in the medical industry, with all the things going on in world with over-hyped or fake viruses should be good for regnum, should be more than a $5mil market cap

The vibe I'm getting from CytoDyn...which is really difficult to read right now...is that their HIV push is really faltering. I have a suspicion any talk of HIV is going to slowly be pushed under the covers. The BLA filing looks more and more distant....if at all.

Hopefully Martin's prior influence and memory is waning and that's a good thing to keep this a clean shell company.

Not sure about expecting headlines or hype. Have you seen ANY PRs from CYDY?

None about their presentations at international conferences. None about their PIPE. Not one about their new President even. Want to know what's going on.... Gotta check their 8-K fillings.

It appears to be the new paradigm post Nader.

regnum needs to extend their contract with cyd as cyd just completed private placement for $21million cash, expecting cyd to start doing something or completing projects.
best bet for cyd would be securing approvals in other countries as bigPharma owns FDA now
regnum needs to find way get rights in other countries to follow on cyd successes
hopefully regnum's relationship is solid with cyd, if so then we should see some news as I expect cyd's 21 million will buy some headlines or hype, got them a new CEO so that is a start

I was referring to the “suppressed image.”

Is it one mans trash is another mans treasure? This company made a bet that cydy has good medical tech and its going to sell in the U.S. market. When that happens regnum will expand into a real company which will easily move the stock price/market value. Like fishing, we are waiting for the fish to come along.

regnum is doing everything they can to keep this clean pink current shell ready. that alone may offer some downside risk. It should be worth it for them to keep this shell alive.

Even if cydy takes too long to get trough the fda this company can pivot to do a deal with other companies because they have lots of Authorized Share upside, low number outstanding, a parent company with money and resources to throw at the right project/product.

because of the share structure / ownership the float is so small that this will move up quickly so no time to chase if confirming news comes out on cydy, that is why this will be a grab some shares and wait

This could be trash but I will wait with stock in hand for this to turn into a treasure

What is this trash?

Good find, lots of those guys out there who invent or cure and then they go away because if it is real and works the big companies buy them off. We saw the scam BigPharma ran on the world with covid & the fake vax that doesnt work, they eliminated other drugs that worked like ivermectin, stopped and slowed ANY trials for covid cures (hundreds of companies had things to help covid never made it past phase 1 at the compromised fda), and they are still going strong after failed trial data and safety problems. Really amazing what a $ billion dollars can buy a company >> monopoly.
Auto and gas industry bought up all the patients and inventions of hydrogen engines and any other engine that did not run on gas. They wanted to keep cars running on gas to preserve the business. Funny how the fake green energy movement is pushing past the resistance gas companies are putting up.

Overall on regnum, they can last a long time as they have cash to survive over a year, can easily get more money if they need to really expand a project, if they continue to keep them pink current I believe they will use this shell for something as there are alot of other drugs in Europe/Israel/Australia that need a small entry company into USA.
CYDY should be able to push through their delays and get back on track, problem is how long will that take,
Now regnum only has 7 months left on that agreement so it will need to be renewed for a longer time. Because of the shorter time left I dont think regnum will invest alot into staff or marketing if they dont have a longer term agreement so they can see returns on their investments. Need to watch for this new agreement as this will tell if cydy is confident in their drug. From that they will provide regnum the inside info that it is real/works, otherwise regnum will not renew if the drug is not good.

downside is regnum parent/owner decides to let this current shell go dormant and write off the money invested. (I dont see this happening as a clean shell is easy to work with)

How long do you think Regnum can hold on?

Anyone know who Dr. Jonah Sacha at OREGON HEALTH & SCIENCE UNIVERSITY is and what he does?

https://reporter.nih.gov/project-details/10371617

Looks like he got almost $1M to perform proof-of-concept for basically an effective *CURE* for HIV. Think about that....not a treatment...but a CURE. If this works in the animal studies it could hopefully evolve into Phase I/II/III studies.

Everyone keeps talking about market share for treatment of MDR groups....How about the whole enchilada putting all the HIV treatment BP companies out of the market. And RGMP still has an agreement with CYDY for HIV treatment marketing/distribution/etc.

Interesting....

I've not heard much about the HIV situation from CytoDyn in a while....plus their trial/safety data is tied up with the Amarex debacle...

Definitely a wait and see period....not truly investing in either right now....flipping yes...

What is your summary of cytodyn this week?
I Noticed stock has moved up this week, to .50 today, has Cytodyn turned up for good, nothing else bad going on, will it last, maybe some other things have been resolved

I expect regnum knows there is a future so they are spending the money on this shell
Too few shares out there, they should do a hype and then sell some shares to get more people involved here

I'm actually quite tempted to grab those on the ASK @ .24 but I think the longer this drags out, the better chance I'll have getting some more under .20.

Thank you for pointing this out. It's something that I had not really thought about.

They can always resell it if it does not work out, to another company to be used in a reverse merger, just as Wookey did. Clean shells with this kind of share structure, with an extremely high insider ownership % will always have value. They have plenty of cash on hand to maintain their filings until they located a merger as well.

Even as an empty shell, with no prospects, its still well worth this price IMO, there are shells out there with FAR higher share structures than this, trading at much higher prices than this.

Even more rumblings that CytoDyn is shifting from HIV to oncology/NASH.

Where does that leave Regnum? Back to reselling scripts?

Please keep in mind that the last agreement that Regnum had with CytoDyn was lead by the former CEO Nader Pourhassan. Not sure if the current BOD are continuing to nurture that relationship/agreement.

Looks like CytoDyn's HIV effort has fizzled out with all HIV study patients put on other therapies and the BLA timeline reevaluated. Other continuing indication research/development (e.g. cancer, NASH, etc) doesn't have any distribution partners lined up that I'm aware of.

What is the Plan B for Regnum if CytoDyn's HIV approvals fall flat on their face?

Liked the $1,500,000 loan from owner to support this project, shows commitment.
They could have bailed on this anytime if cydy didnt have anything. I assume they had some good meetings with cydy to have confidence to continue spending money on this project.
Another quarter of money and resources spent keeping this current.
Wish they would spend some money on PR to explain what the plan is however their probably waiting for the all clear at cydy. That stock will also take off when fda lifts the hold.
Only concern here is the lack of liquidity, # of shares, that may keep some bigger investors from buying in (which is probably good, less manipulation?). I believe they will create some news to drive price up and then do a stock offering to collect more funds to launch their plans.
Small companies like this seem to target $5 so that is my prediction for 2023, all assuming the cydy hold is lifted

Yes. Pleasant surprise. His halfway-house supervision will most likely be 6-12 months. Highly controlled environment most likely with GPS ankle bracelet monitoring.

Let's see how much he can honestly follow the courts' restrictions and guidance on his release terms.

You see Marty got released from prison...??

https://www.cnbc.com/2022/05/18/martin-shkreli-released-from-federal-prison-into-halfway-house-.html

Don't know but as far as reading her book, I think that's going to be a hard pass for me......lol.

I wonder if there will be any mention of Vyera, Regnum, et all in the new book by Martin's former girlfriend...it's titled "Smirk"....

https://www.elle.com/culture/a39893396/christie-smythe-martin-shkreli-memoir-2022/

p.s. Good to hear the positive news on your wife.

Thanks, she seems to be fine now, hopefully it was just a one time thing.

I don't know if its the Shkreli connection, very well could be.......or just FINRA taking forever, I'm waiting on name/symbol change in another one of my stocks that's also taking an eternity.

If it is Shkreli holding up things, you would think once this happens, it will close the door on the whole Marty saga and the company can then move forward.

Mr. Shkreli’s equity interest in Phoenixus is presently in the process of being sold by a receiver in order to satisfy certain monetary damages owed by Mr. Shkreli arising out of such legal proceedings.

BB, I hope all is improving for your wife.

Wondering if the SEC is ever going to approve Regnum's name change request. Knowing that Shkreli is still under the SEC/DOJ microscope, will Vyera, et al ever get clear of his cloud that seems to continue stalling forward progress?

Yes, very serious, one second we were walking around Walmart just fine....and the next she collapsed and was unconscious for a couple minutes. By the time EMS and the fire dept got there, she was starting to feel better and was able to stand up and walk again but it was a very scary situation...... and there is no doubt in my mind it's a reaction from the booster, as the problems started at the same time.

We waited about 6 months after the vax came out to get it, honestly we didn't really want too but the fear mongering in the media was reaching epic proportions, showing people on their death beds, dying of COVID, crying 'I wish I would have got the vaccine'......so we finally broke down and got it.

Now were paying the price for it, literally, just the EMS response yesterday is going to be $650 and she was not even transported to the hospital.

Anyway, thanks for the info, I'm going look into this today about how to get the vax out of your system.

brother, if you are serious then that is very sad to hear, will pray for you both.
Look up on rumble.com everything to learn on side effects they are not telling people. substack also has some really good writers on what is happening in medical industry.
Also research how to re-build your immune system. re-build the cd8 t-cell response for yourself and wife to get rid of the vax in your system.

two yrs ago we had the Big Covid Drug rush, this year is going to be the big drug rush to correct all the side effects from the mass vax campaign. that is why pfizer is buying up heart companies and immune support drug companies. they have been creating a whole new customer base for the next problems.

mRNA drug can stay in some people's system for up to 12+ months so it is still working and causing problems, attaching or compromising the immune system. cydy drug will help if they can get it through trials, maybe they need to start a new path along with the hiv, to help protect the good t-cells for the immune system.

would like to see rgmp and their resources get active to help cydy

Oh, I know, my wife has been having major side effects from the Pfizer booster. She was fine for the first two shots but since the day of the booster has been very ill, some kind of immune response symptom, one that they don't tell you about, that apparently over 140K women have had.

She collapsed and passed out at Walmart yesterday, thankfully I caught her before she hit the ground.... and there happened to be a nurse shopping who was right there and called EMS for us, her pulse dropped to 40 bpm......very scary stuff as she has never fainted before in her life.

I'm not some anti-vax, tin foil hat wearing nutter either, but I can say for sure neither of us is getting that f*ckin jab again.

Just hired CFO for part time basis, spent alot of money last 12 months to get this current & keep it current, Annual Report shows they put more money into this, Maybe they like the cydy drug

my opinion it it shows they are going to at least try to make something here.
All efforts are based on cydy drug per annual report.
They know about drug hold up and still moving forward so that may indicate cydy believes the administrative hold may not last long,

One item to note is medical research is showing that some people who get the vax booster and continue with multiple booster shots, the more problems their immune system can have and potentially result in AIDS - acquired immunodeficiency syndrome. Med Industry is working on this as result of mass vax campaign.

HIV (human immunodeficiency virus) is a virus that attacks cells that help the body fight infection, making a person more vulnerable to other infections and diseases.

I think this company will need to be ready and will move quick when cydy's hold is resolved because the medical community will need treatment for all the mass vax side effects that are coming

It's been suggested that the COMMERCIALIZATION AND LICENSE AGREEMENT and the SUPPLY AGREEMENT, both dated December 17, 2019, and both between Vyera Pharmaceuticals, LLC, and CytoDyn Inc. relate to the relationship of what constitutes control of CytoDyn's IP by Regnum through these agreements.

I'm not a contractual lawyer and these are pretty lengthy documents....any help from the crowd ?

https://www.sec.gov/Archives/edgar/data/1716324/000147793222002416/rgmp_ex101.htm

https://www.sec.gov/Archives/edgar/data/1716324/000147793222002416/rgmp_ex102.htm

Anyone's guess as to what IP did CytoDyn allow RGMP access or control to?

(Quote from recent 10-K)
Third parties may in the future make claims challenging the inventorship or ownership of our intellectual property. We have written agreements with CytoDyn that provide for the ownership of intellectual property underlying the leronlimab product candidate. We may face claims by third parties that our agreements with CytoDyn are ineffective, or in conflict with prior or competing contractual obligations of assignment, which could result in ownership disputes regarding intellectual property we have developed or will develop and interfere with our ability to capture the commercial value of such inventions. Litigation may be necessary to resolve an ownership dispute, and if we are not successful, we may be precluded from using certain intellectual property, or may lose our exclusive rights in that intellectual property. Either outcome could have an adverse impact on our business.

Here's a tutorial from a spanish language website on how to buy your RGMP shares...


https://educacep-es.translate.goog/comprar-acciones-regnum/?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp

Does Regnum have *ANY* future/potential revenue sources other than CytoDyn?

Wanted to share the link for the 10-K late filing notice:

https://www.sec.gov/Archives/edgar/data/1716324/000147793222001848/rgmp_nt10k.htm

Looks like CytoDyn's HIV BLA is going to be pushed out at least a year...I'm thinking earliest Q1 CY2023.

Treading water here....

Definitely a longer term hold but not concerned at all. If it gets dumped down a bit further while we wait, I'll add some more for sure.

Extension Filed for Annual Report, looking at the legal, professional, general expense dollars for 2021 in this filing I would assume that they are going to keep this current and make something happen with this shell and the HIV drug license.
Good Sign

Hopefully by April 15 the annual report will provide info on their business & marketing plan. This is really the news that will move the stock price up. Also exposure is needed badly.

Actually expecting a mini road show to raise the stock price so they can sell some shares to raise cash. I know they need money and there are plenty of shares they can sell without diluting their control.

Just a quick update. Looks like a new domain related to "Regnum Corp" has been registered. No idea if it's some sort of domain squatting effort.

https://www.regnum-corp.com/

The WhoIs entry is:
https://www.whois.com/whois/regnum-corp.com

No change to the "new" company's website at https://www.rovidatx.com ....

Of course, everything is under construction.

Isn't a 10-Q supposed to be out?

Last one was for period ending 30Jun2021.

I am Investing/gambling on the situation I see, not really the company

I like where your head is at. Makes logical sense to me.

Wow. The US Government really does despise poor Martin. No blogging or other influence about/to pharma companies.

So, I don't expect guest editorials from Martin on the new https://www.rovidatx.com website....which, by the way, got a makeover with it's "Coming Soon" banner.

NOTE: Be on the lookout for a Rovida Therapeutics Twitter presence, the "Coming Soon" page had invisible references to it.

...Objecting that one of the prohibitions in the injunction is vague and violates his First Amendment rights, Shkreli questions whether he would be prohibited from using a blog to discuss the pharmaceutical industry by the bar against him taking any action to influence the management of a Pharmaceutical Company. This provision is not vague. It bars him from taking actions to influence the management of a Pharmaceutical Company even through publicly issued statements. While First Amendment rights are deserving of great protection, Shkreli’s violations of the antitrust laws have lost for him the right to speak publicly about the pharmaceutical industry when such speech is uttered to influence the management or business of a Pharmaceutical Company. See Peregrine, 89 F.3d at 51 (finding that an injunction restraining the defendant from communicating with the management of a joint venture from which she was also enjoined from being involved was not overbroad).

To further respond to Shkreli’s objection, the following clause will be added to provision II.D.: Shkreli’s public statements about a Pharmaceutical Company will be deemed an action taken to influence or control the management or business of any Pharmaceutical Company if Shkreli intended the statement to have that effect or if a reasonable person would conclude that the statement has that effect….

https://martinshkrelilacksjudgment.files.wordpress.com/2022/02/shk-actual-injunction-daraprim-terms-2022.pdf

NEW YORK, Feb 4 (Reuters) - A U.S. judge on Friday rejected former pharmaceutical executive Martin Shkreli's objections to being banned for life from the drug industry and having to repay $64.6 million after jacking up the price of a lifesaving drug.

https://www.reuters.com/world/us/us-judge-rejects-shkrelis-objections-lifetime-drug-industry-ban-2022-02-04/

Not sure how much the US Gov despises poor Marty....but they're really trying to show that they do with a vengeance. If anyone felt that the books of Sevenscore and Regnum needed a closer look....I can almost guarantee that they will .....for a long time to come....

The FTC formally answered Martin’s objections to the life-time banning order (as proposed) and now under review by the able USDC Chief Judge Cote, in Manhattan.

https://martinshkrelilacksjudgment.files.wordpress.com/2022/02/shkreli-ftc-ans-banning-obj-02-02-2022.pdf

In the FTC’s accompanying ten page memo of law explaining why such a broad ban is needed, consistent with the Judge’s earlier holdings...
https://martinshkrelilacksjudgment.files.wordpress.com/2022/02/shkreli-ftc-ans-banning-obj-02-02-2022.pdf

More details at: https://martinshkrelilacksjudgment.wordpress.com/2022/02/03/fascinating-disclosure-from-ftc-of-an-in-jail-letter-martin-just-received-a-week-or-two-ago/